Clifford Saffron
Vorstandsvorsitzender bei OPTIMUS HEALTHCARE SERVICES, INC.
Aktive Positionen von Clifford Saffron
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| OPTIMUS HEALTHCARE SERVICES, INC. | Vorstandsvorsitzender | 27.07.2023 | - |
| Geschäftsführer | 10.07.2023 | - | |
| General Counsel | 01.04.2021 | - | |
| Präsident | 27.07.2023 | - | |
| Finanzdirektor/CFO | 01.04.2021 | 03.04.2023 |
Karriereverlauf von Clifford Saffron
Ehemalige bekannte Positionen von Clifford Saffron
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Animal Surgical Center of Michigan LLC | Vorstandsvorsitzender | 01.03.2020 | 01.03.2021 |
Hoffman Technologies, Inc.
 Hoffman Technologies, Inc. Information Technology ServicesTechnology Services Hoffman Technologies, Inc. provides information technology services. It offers technology hardware, software, and services resale. The firm also offers technology products, technology services, office supplies, janitorial supplies, tactical supplies, industrial supplies, and various other consumer and consumable products. It also offers services to distributors, wholesalers, retailers and manufacturers. The company was founded by Gary C. Hoffman and Kevin Hoffman in 1997 and is headquartered in Rocklin, CA. | Präsident | 01.10.2018 | 01.03.2020 |
Yamo Pharmaceuticals LLC
 Yamo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Yamo Pharmaceuticals LLC is a clinical stage pharmaceutical company that was founded in 2015. Yamo Pharmaceuticals is a privately held company and is based in New York, NY. The company's focus is on developing L1-79, a novel therapy that has the potential to improve the core symptoms of ASD. The CEO of the company is Charles J. Bramlage. | Corporate Officer/Principal | 01.10.2018 | 01.03.2020 |
| Kps Life Sciences | Corporate Officer/Principal | 01.10.2018 | 01.03.2020 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | General Counsel | 01.02.2002 | 01.02.2005 |
| ICN Pharmaceuticals, Inc. /Old/ | Corporate Officer/Principal | 01.01.1994 | 01.01.2001 |
Statistik
International
| Vereinigte Staaten | 7 |
| Deutschland | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| General Counsel | 2 |
| Chief Executive Officer | 2 |
Sektoral
| Health Technology | 4 |
| Consumer Non-Durables | 2 |
| Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OPTIMUS HEALTHCARE SERVICES, INC. | Consumer Non-Durables |
| Private Unternehmen | 6 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
Hoffman Technologies, Inc.
Hoffman Technologies, Inc. Information Technology ServicesTechnology Services Hoffman Technologies, Inc. provides information technology services. It offers technology hardware, software, and services resale. The firm also offers technology products, technology services, office supplies, janitorial supplies, tactical supplies, industrial supplies, and various other consumer and consumable products. It also offers services to distributors, wholesalers, retailers and manufacturers. The company was founded by Gary C. Hoffman and Kevin Hoffman in 1997 and is headquartered in Rocklin, CA. | Technology Services |
| ICN Pharmaceuticals, Inc. /Old/ | Health Technology |
Yamo Pharmaceuticals LLC
Yamo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Yamo Pharmaceuticals LLC is a clinical stage pharmaceutical company that was founded in 2015. Yamo Pharmaceuticals is a privately held company and is based in New York, NY. The company's focus is on developing L1-79, a novel therapy that has the potential to improve the core symptoms of ASD. The CEO of the company is Charles J. Bramlage. | Health Technology |
| Kps Life Sciences | |
| Animal Surgical Center of Michigan LLC |
- Börse
- Insiders
- Clifford Saffron
- Erfahrung
